androstenedione~|~myocardial infarction~|~cercopithecidae~|~platyrrhini~|~attention deficit disorder~|~attention deficit hyperactivity disorder~|~diarrhea~|~monkeys~|~personnel selection~|~vomiting~|~wheezing~|~disease~|~specific qualifier value~|~add action code~|~add - dosing instruction fragment~|~add - instruction imperative~|~additional~|~diarrhea, ctcae~|~electrocardiogram: myocardial infarction (finding)~|~from~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~myocardial infarction ecg assessment~|~myocardial infarction, ctcae~|~myocardial infarction:finding:point in time:^patient:ordinal~|~not otherwise specified~|~tissue membrane~|~usual severity diarrhea~|~bothered by night sweats~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~night sweats~|~usual severity vomiting~|~vomiting, ctcae~|~wheezing, ctcae
androstenedione~|~dyspnea~|~physicians~|~disease~|~eye~|~attention deficit disorder~|~attention deficit hyperactivity disorder~|~personnel selection~|~primary cough headache~|~tissue membrane~|~add action code~|~add - dosing instruction fragment~|~add - instruction imperative~|~additional~|~brief health literacy screening tool~|~behavior rating inventory of executive function~|~brief~|~entire eye~|~eye specimen~|~eye specimen source code~|~have shortness of breath question~|~high~|~how much distress shortness of breath~|~how often shortness of breath~|~membranous~|~off~|~orbital region~|~shortened~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~doctor - title
apnea~|~apnea, ctcae~|~not otherwise specified
apnea~|~fascia~|~hac protocol~|~apnea, ctcae~|~entire fascia~|~hadh gene~|~have~|~not otherwise specified~|~suicide attempt incident code~|~suicide attempt, ctcae~|~suicide attempt
hematemesis~|~hemorrhage~|~not otherwise specified~|~nausea and vomiting
chest pain~|~chest pain:finding:point in time:^patient:ordinal~|~specific qualifier value
hypoglycemia~|~hypoglycemia, ctcae
dyspnea~|~chronic obstructive airway disease~|~xerostomia~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~external cause codes: unspecified~|~nr4a2 gene~|~negation~|~not otherwise specified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~dry mouth, ctcae~|~have dry mouth~|~how much distress dry mouth~|~how often dry mouth~|~usual severity dry mouth
abdominal pain~|~hemorrhoids~|~andorra~|~behavior~|~and~|~and - dosing instruction fragment~|~behavior:-:point in time:^patient:-~|~changed status~|~changing~|~have~|~hemorrhoids, ctcae 3.0~|~hemorrhoids, ctcae 5.0~|~mental state~|~not otherwise specified~|~rectum/anus~|~relationshipconjunction - and~|~specific qualifier value~|~abdominal pain, ctcae 5~|~muscle strain
fever~|~wheezing~|~chills~|~disease~|~chills, ctcae~|~in addition to~|~membranous~|~tissue membrane~|~with - dosing instruction fragment~|~wheezing, ctcae
fatigue~|~hypertension, ctcae~|~hypertensive disease~|~not otherwise specified~|~postural~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue
hypothyroidism~|~signs and symptoms~|~changed status~|~changing~|~mental state~|~not otherwise specified~|~blood products laboratory testing~|~general symptom~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
muscle cramp~|~pain~|~chest pain~|~spasm~|~brothers~|~anxiety~|~chest~|~not otherwise specified~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~brother - courtesy title~|~entire thorax~|~facilitated oscillatory release technique~|~generalized~|~injury of lower leg~|~injury of thigh~|~kantr gene~|~preposition for~|~relationship - brother~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~wwox gene~|~wwox wt allele~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
hyperventilation~|~anxiety~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~not otherwise specified
asthma~|~dyspnea~|~disease~|~respiration disorders~|~signs and symptoms~|~acute bronchospasm~|~asthma pathway~|~external cause codes: unspecified~|~facilitated oscillatory release technique~|~fighting~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~in addition to~|~preposition for~|~respiratory tract diseases~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity shortness of breath~|~wwox gene~|~wwox wt allele~|~with - dosing instruction fragment~|~exacerbation acute~|~general symptom
syncope~|~dyspnea~|~andorra~|~and~|~and - dosing instruction fragment~|~collapse (finding)~|~collapsed~|~relationshipconjunction - and~|~external cause codes: unspecified~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~hypertension, ctcae~|~hypertensive disease~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~syncope (amphibian)~|~syncope, ctcae 5.0~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity shortness of breath
eye~|~pain~|~andorra~|~leg~|~histone acetyltransferase~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~traumatic injury~|~august~|~entire eye~|~eye specimen~|~eye specimen source code~|~orbital region~|~traumatic and/or non-traumatic injury~|~fighting~|~haitian creole language~|~hat - headwear~|~nr4a2 gene~|~negation~|~tmprss11d gene~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~open wound of eyeball~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
chest pain~|~atrial fibrillation~|~facilitated oscillatory release technique~|~nr4a2 gene~|~negation~|~preposition for~|~wwox gene~|~wwox wt allele~|~chest pain:finding:point in time:^patient:ordinal~|~atrial fibrillation by ecg finding~|~atrial fibrillation, ctcae~|~ever told you have or had atrial fibrillation:finding:point in time:^patient:ordinal~|~external cause codes: unspecified~|~like~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~scenario~|~bothered by night sweats~|~fine - adjective~|~legal fine~|~night sweats
muscle spasticity~|~spastic~|~forearm injuries~|~hemorrhage~|~fear (mental process)~|~injury of lower leg~|~nr4a2 gene~|~negation~|~not otherwise specified~|~specific qualifier value~|~generalized aches and pains
influenza~|~aspirin~|~dyspnea~|~influenza virus vaccine~|~andorra~|~influenza virus~|~orthomyxoviridae~|~adult~|~health~|~and~|~and - dosing instruction fragment~|~communication contact~|~contact - hl7 attribution~|~contact with~|~container status - identified~|~due to~|~fighting~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~identified~|~medical examination~|~nr4a2 gene~|~negation~|~not otherwise specified~|~personal contact~|~physical contact~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~contact person~|~legal adult
fever with chills~|~not otherwise specified
changed status~|~changing~|~have~|~mental state~|~not otherwise specified~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
dehydration~|~poisoning~|~biopharmaceuticals~|~andorra~|~signs and symptoms~|~and~|~and - dosing instruction fragment~|~biological factors~|~butting~|~dehydration procedure~|~dehydration, ctcae~|~drugs - dental services~|~hypertension, ctcae~|~hypertensive disease~|~indeterminate~|~pharmaceutical preparations~|~relationshipconjunction - and~|~specific qualifier value~|~substance~|~undetermined~|~undetermined finding~|~general symptom~|~poisoning aspects
vision~|~chills~|~chills, ctcae~|~in addition to~|~see~|~with - dosing instruction fragment
dyspnea~|~major depressive disorder~|~unipolar depression~|~andorra~|~behavior~|~adjacent~|~and~|~and - dosing instruction fragment~|~behavior:-:point in time:^patient:-~|~following~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~subsequent trial activity~|~then~|~usual severity shortness of breath~|~next - htmllinktype~|~muscle strain~|~symptoms and signs involving emotional state
tachycardia~|~sepsis~|~eye drops~|~septicemia~|~severe sepsis~|~disease~|~external cause codes: unspecified~|~eye drops brand of tetrahydrozoline~|~in addition to~|~organism~|~sepsis (invertebrate)~|~sepsis, ctcae~|~severe sepsis with septic shock~|~tissue membrane~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~receptor~|~fever with chills~|~respiration intermittent
pain~|~back pain~|~nr4a2 gene~|~negation~|~not otherwise specified~|~administration method - pain~|~adverse event associated with pain~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~feel pain~|~frequency of pain question~|~general medical service~|~generalized~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~safety reporting documentation~|~united states military commissioned officer o10~|~usual severity pain
aspirin~|~chest pain~|~alcohol consumption~|~external cause codes: unspecified~|~fighting~|~in addition to~|~intoxication~|~not otherwise specified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~chest pain:finding:point in time:^patient:ordinal
sepsis~|~communicable diseases~|~septicemia~|~somnolence~|~adverse event associated with infection~|~changed status~|~changing~|~drowsiness~|~drowsiness visual analogue scale~|~external cause codes: unspecified~|~infection~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~organism~|~sepsis (invertebrate)~|~sepsis, ctcae~|~skin and subcutaneous tissue structure~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~local~|~local remote control state - local~|~local-regional anatomy
aspirin~|~abdominal pain~|~not otherwise specified~|~specific qualifier value~|~hypertension, ctcae~|~hypertensive disease~|~mental status change~|~abdominal pain, ctcae 5~|~abdominal tenderness
syncope~|~transient ischemic attack~|~andorra~|~skin~|~and~|~and - dosing instruction fragment~|~entire skin~|~entity~|~relationshipconjunction - and~|~skin specimen~|~skin specimen source code~|~skin, human
androstenedione~|~asthma~|~chest pain~|~attention deficit disorder~|~attention deficit hyperactivity disorder~|~wheezing~|~disease~|~left upper quadrant pain~|~right upper quadrant pain~|~add action code~|~add - dosing instruction fragment~|~add - instruction imperative~|~additional~|~asthma pathway~|~in addition to~|~specific qualifier value~|~tissue membrane~|~with - dosing instruction fragment~|~exacerbation acute~|~chest pain:finding:point in time:^patient:ordinal~|~wheezing, ctcae
pain~|~alcohol consumption~|~dyspnea~|~specific qualifier value~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~external cause codes: unspecified~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~in addition to~|~intoxication~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~smell of alcohol on breath~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity shortness of breath~|~with - dosing instruction fragment
seizures~|~fingers~|~wrist joint~|~hand~|~wrist~|~andorra~|~not otherwise specified~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~and~|~and - dosing instruction fragment~|~entire hand~|~entire wrist region~|~external cause codes: unspecified~|~fecal immunochemical test~|~fingers, unit of measurement~|~fit (action)~|~fit and well~|~prosthesis fit~|~relationshipconjunction - and~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~hand - unit of measure
myocardial infarction~|~acute myocardial infarction~|~electrocardiogram: myocardial infarction (finding)~|~elevation~|~elevation procedure~|~external cause codes: unspecified~|~myocardial infarction ecg assessment~|~myocardial infarction, ctcae~|~myocardial infarction:finding:point in time:^patient:ordinal~|~not otherwise specified~|~send (transmission)~|~standard for the exchange of nonclinical data~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~anterior wall~|~chest wall pain
fingers~|~andorra~|~face~|~wrist injuries~|~not otherwise specified~|~and~|~and - dosing instruction fragment~|~elovl6 gene~|~entire face~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~fingers, unit of measurement~|~fracture~|~fracture of medical device material~|~fracture, ctcae~|~heart beat~|~herero language~|~nearly~|~relationshipconjunction - and~|~rubricyte count~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hand and wrist~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~fine - adjective~|~hypertensive disease~|~legal fine~|~pressure injury
abdominal pain~|~chest pain~|~nausea~|~bothered by nausea~|~breath~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~abdominal pain, ctcae 5~|~chest pain:finding:point in time:^patient:ordinal~|~general medical service~|~generalized~|~safety reporting documentation~|~united states military commissioned officer o10
abdomen distended~|~abdominal bloating~|~bloating, ctcae~|~irritation~|~irritation (finding)~|~irritation - emotion~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~generalized abdominal pain~|~hypertensive disease~|~nausea or abdominal pain
xerostomia~|~specific qualifier value~|~dry mouth, ctcae~|~have dry mouth~|~how much distress dry mouth~|~how often dry mouth~|~usual severity dry mouth
eye drops~|~disease~|~breast~|~acute pulmonary edema~|~childhood immunization~|~eye drops brand of tetrahydrozoline~|~tissue membrane~|~worried~|~yes portal~|~yes1 gene~|~yes1 wt allele~|~yes (indicator)~|~yes - assignment of benefits~|~yes - event expected~|~yes - event seriousness~|~yes - expanded yes/no indicator~|~yes - identity may be divulged~|~yes - notify clergy code~|~yes - presence findings~|~yes - release information~|~yes - yes/no indicator
not otherwise specified~|~abdominal tenderness
androstenedione~|~chest pain~|~tachycardia~|~dyspnea~|~attention deficit disorder~|~attention deficit hyperactivity disorder~|~nausea~|~disease~|~chest pain:finding:point in time:^patient:ordinal~|~add action code~|~add - dosing instruction fragment~|~add - instruction imperative~|~additional~|~bothered by nausea~|~feel nausea~|~have nausea~|~have shortness of breath question~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~membranous~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~tissue membrane~|~usual severity nausea~|~usual severity shortness of breath~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
alcohol consumption~|~heart injuries~|~specific qualifier value~|~andorra~|~and~|~and - dosing instruction fragment~|~in addition to~|~not otherwise specified~|~relationshipconjunction - and~|~to specify~|~with - dosing instruction fragment
urinary tract infection~|~andorra~|~dysuria~|~and~|~and - dosing instruction fragment~|~breath~|~childhood immunization~|~not otherwise specified~|~relationshipconjunction - and~|~dysuria, ctcae~|~infection by site~|~recurrent urinary tract infection~|~this (eukaryote)~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~urinary tract infection, ctcae~|~yes portal~|~yes1 gene~|~yes1 wt allele~|~yes (indicator)~|~yes - assignment of benefits~|~yes - event expected~|~yes - event seriousness~|~yes - expanded yes/no indicator~|~yes - identity may be divulged~|~yes - notify clergy code~|~yes - presence findings~|~yes - release information~|~yes - yes/no indicator~|~chronic - admission level of care code~|~provision of recurring care for chronic illness~|~chronic
generalized abdominal pain
nausea~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea
homo sapiens~|~dehydration~|~dementia~|~back pain~|~ask protein, human~|~males~|~presenile dementia~|~not otherwise specified~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~dbf4 gene~|~dbf4 wt allele~|~dehydration procedure~|~dehydration, ctcae~|~entity determiner - specific~|~external cause codes: unspecified~|~fighting~|~in addition to~|~male population group~|~man chinese~|~mandinka language~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~aggressive behavior~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~specific qualifier value
andorra~|~venoms~|~snake venoms~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~accidents~|~dental health services~|~foundation for the accreditation of cellular therapy~|~international~|~toxic~|~toxic effect~|~signs and symptoms~|~accidental~|~body parts - dental~|~counter brand of terbufos~|~counter device~|~dental~|~dental (intended site)~|~dental route of drug administration~|~dental dosage form~|~dental:-:point in time:^patient:-~|~external cause codes: unspecified~|~national citizen~|~school type - dental~|~specialized stand alone plan - dental~|~specific qualifier value~|~undressed~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~venom (disposition)~|~very~|~very much~|~general symptom
arthralgia~|~crohn disease~|~hemorrhage~|~body site modifier - lower~|~lower (action)~|~lower - spatial qualifier~|~not otherwise specified~|~generalized abdominal pain~|~generalized aches and pains~|~joint pain, ctcae 3~|~left~|~left sided~|~level of joint pain~|~right~|~right sided~|~table cell horizontal align - left~|~table cell horizontal align - right
chest pain~|~chest pain:finding:point in time:^patient:ordinal~|~external cause codes: unspecified~|~nasal sinus~|~not otherwise specified~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~pathologic fistula
cold temperature~|~common cold~|~forearm~|~hallucinations, auditory~|~chronic obstructive airway disease~|~hallucinations, visual~|~upper respiratory infections~|~andorra~|~inpatient~|~academic degree~|~degree or extent~|~burn injury~|~and~|~and - dosing instruction fragment~|~degree unit of plane angle~|~facilitated oscillatory release technique~|~first (number)~|~firstly~|~levels (qualifier value)~|~nr4a2 gene~|~negation~|~patient class - inpatient~|~preposition for~|~referral category - inpatient~|~relationshipconjunction - and~|~side~|~specific qualifier value~|~this (eukaryote)~|~wwox gene~|~wwox wt allele~|~inpatient encounter~|~burn specimen~|~burn specimen source codes~|~burn, ctcae~|~cold sensation~|~partial thickness burn of lower leg~|~symptoms and signs involving emotional state~|~thermal decomposition of device~|~usage~|~use - dosing instruction imperative~|~utilization qualifier
changed status~|~changing~|~mental state~|~not otherwise specified~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
chest pain~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal
generalized abdominal pain~|~abdomen distended~|~abdominal bloating~|~bloating, ctcae~|~specific qualifier value~|~generalized aches and pains~|~specimen source codes - tears~|~tears - specimentype~|~tears body substance
androstenedione~|~tachycardia~|~pain~|~disease~|~attention deficit disorder~|~attention deficit hyperactivity disorder~|~eye drops~|~add action code~|~add - dosing instruction fragment~|~add - instruction imperative~|~additional~|~eye drops brand of tetrahydrozoline~|~membranous~|~tissue membrane~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~hyaline membrane~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
dizziness~|~chest pain~|~lightheadedness~|~vertigo, peripheral~|~not otherwise specified~|~chest pain:finding:point in time:^patient:ordinal
specific qualifier value~|~this (eukaryote)
andorra~|~allergic reaction~|~allergy specialty~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~hypersensitivity~|~allergic disposition~|~allergy - charge type reason~|~behavior:-:point in time:^patient:-~|~drug-induced dystonia~|~response to antigens~|~symptoms and signs involving emotional state
not otherwise specified
awareness~|~poisoning~|~hypoxemia~|~alteration~|~administration procedure~|~biomaterial treatment~|~butting~|~metabolic~|~metabolic process, cellular~|~metabolic:-:point in time:^patient:-~|~present~|~presentation~|~specific qualifier value~|~therapeutic procedure~|~treating~|~treatment epoch~|~treatment study~|~therapeutic aspects~|~treatment - actinformationmanagementreason~|~poisoning aspects
hypertension, ctcae~|~hypertensive disease~|~specific qualifier value
asthma~|~counseling~|~dyspnea~|~andorra~|~asthenia~|~disease~|~and~|~and - dosing instruction fragment~|~facilitated oscillatory release technique~|~preposition for~|~relationshipconjunction - and~|~wwox gene~|~wwox wt allele~|~absent~|~asthma pathway~|~clinical observation~|~cough frequency~|~cough, ctcae~|~coughing~|~counter brand of terbufos~|~counter device~|~fighting~|~have been coughing~|~have shortness of breath question~|~how much distress cough~|~how much distress shortness of breath~|~how often shortness of breath~|~negative~|~not otherwise specified~|~observation - diagnostic procedure~|~observation in research~|~observation regimes~|~others - allergy~|~patient observation~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specialty type - observation~|~suspected diagnosis~|~suspected qualifier~|~this (eukaryote)~|~usual severity cough~|~usual severity shortness of breath~|~worried~|~act - observation~|~other medicated shampoos in atc~|~violent~|~abnormal breathing~|~entity determiner - specific~|~specific qualifier value
diarrhea~|~diarrhea, ctcae~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~usual severity diarrhea~|~epigastric pain~|~right upper quadrant pain~|~external cause codes: unspecified~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~generalized abdominal pain
headache~|~neck injuries~|~fighting~|~headache, ctcae~|~not otherwise specified~|~entity determiner - specific~|~generalized aches and pains~|~specific qualifier value
not otherwise specified~|~chest pain on breathing~|~exist~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~obstruction~|~obstruction within medical device~|~tests (qualifier value)~|~abdominal tenderness~|~generalized abdominal pain~|~nausea or abdominal pain
italy~|~not otherwise specified~|~intrathecal route of drug administration
chest pain~|~dyspnea~|~nausea~|~chest pain:finding:point in time:^patient:ordinal~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~have shortness of breath question~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~usual severity shortness of breath~|~chest pain on breathing
lidocaine~|~andorra~|~epileptic syndromes~|~relaxation~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~not otherwise specified~|~idiopathic epilepsy~|~general medical service~|~generalized~|~relaxed~|~safety reporting documentation~|~united states military commissioned officer o10
tachycardia~|~wheezing~|~disease~|~adult~|~membranous~|~specific qualifier value~|~tissue membrane~|~legal adult~|~wheezing, ctcae
andorra~|~dehydration~|~attention~|~hypoglycemia~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~able to concentrate question~|~attention g-code~|~behavior:-:point in time:^patient:-~|~concentration measurement~|~dehydration procedure~|~dehydration, ctcae~|~hypoglycemia, ctcae~|~mental concentration~|~patient visit~|~specific qualifier value~|~visit~|~visit name~|~muscle strain
pneumonia~|~dyspnea~|~disease~|~diffuse optical tomography~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~organism~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~tissue membrane~|~usual severity shortness of breath
urinary retention~|~urologic diseases~|~abdomen~|~specific qualifier value~|~chairs~|~emotional tenderness~|~external cause codes: unspecified~|~in addition to~|~not otherwise specified~|~numerous~|~several~|~sore to touch~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~abdominal (qualifier value)~|~generalized abdominal pain~|~nausea and vomiting
back pain~|~hypoglycemia~|~hypoglycemia, ctcae~|~not otherwise specified~|~tendency to fall~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0
eczema~|~alcohol related disorders~|~alcohol consumption~|~specific qualifier value~|~signs and symptoms~|~eczema, ctcae~|~general symptom~|~internal~|~within
asthma~|~dyspnea~|~eye drops~|~wheezing~|~disease~|~asthma pathway~|~eye drops brand of tetrahydrozoline~|~have~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~in addition to~|~possess~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~tissue membrane~|~usual severity shortness of breath~|~with - dosing instruction fragment~|~exacerbation acute~|~wheezing, ctcae
sinoatrial node~|~cardiac arrhythmia~|~chest pain~|~artificial cardiac pacemaker~|~defibrillators~|~heart~|~signs and symptoms~|~adverse event associated with cardiac arrhythmia~|~automated (qualifier value)~|~cardiac - anatomy qualifier~|~external cause codes: unspecified~|~implants~|~in addition to~|~specific qualifier value~|~synchronous~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~chest pain:finding:point in time:^patient:ordinal~|~general symptom
dyspnea~|~chest pain~|~physical examination~|~encounter~|~facilitated oscillatory release technique~|~healthcare encounter~|~medical examination~|~patient visit~|~preposition for~|~visit~|~wwox gene~|~wwox wt allele~|~health~|~cdisc findings class~|~cdisc sdtm adverse event outcome terminology~|~examination~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~out (direction)~|~procedure findings:finding:point in time:^patient:narrative~|~removed~|~result~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~tcf23 gene~|~usual severity shortness of breath~|~without~|~counts~|~findings aspects~|~abnormal~|~abnormal reference range~|~admission type - routine~|~chest pain:finding:point in time:^patient:ordinal~|~extended priority codes - routine~|~level of care - routine~|~observation interpretation - abnormal~|~priority - routine~|~processing priority - routine~|~referral priority - routine~|~report priority - routine~|~routine
back pain~|~nausea~|~acute gastritis~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~usual severity nausea~|~acute abdominal pain~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~generalized abdominal pain
back pain~|~fighting~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~body site modifier - lower~|~external cause codes: unspecified~|~like~|~lower (action)~|~lower - spatial qualifier~|~lower back (surface region)~|~lower back structure~|~not otherwise specified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~entity determiner - specific~|~specific qualifier value~|~indurated
nausea and vomiting
changed status~|~changing~|~mental state~|~not otherwise specified~|~laboratory procedures~|~tests (qualifier value)
andorra~|~ask protein, human~|~cardiac arrest~|~and~|~and - dosing instruction fragment~|~aspects of mortality statistics~|~mortality vital statistics~|~relationshipconjunction - and~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~cardiac arrest, ctcae 5~|~dbf4 gene~|~dbf4 wt allele~|~dcstamp gene~|~finding~|~specific qualifier value~|~etiology aspects~|~science of etiology
dehydration~|~food~|~back pain~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~specific qualifier value~|~fighting~|~lower back (surface region)~|~lower back structure~|~entity determiner - specific~|~dehydration procedure~|~dehydration, ctcae~|~food allergenic extracts~|~not otherwise specified~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0
changed status~|~changing~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified
electromagnetic radiation~|~poisoning~|~united arab emirates~|~andorra~|~radiation~|~and~|~and - dosing instruction fragment~|~androgen response element~|~biological factors~|~determined by~|~drugs - dental services~|~pharmaceutical preparations~|~resf1 gene~|~radiation ionizing radiotherapy~|~radiotherapy research~|~rash and dermatitis associated with radiation excluding chemoradiation, ctcae~|~relationshipconjunction - and~|~therapeutic radiology procedure~|~unit of radiation dose~|~are unit of measure~|~entity determiner - specific~|~internal~|~irritability and anger~|~specific qualifier value~|~symptoms and signs involving emotional state~|~within
rectum~|~rectal diseases~|~hemorrhage~|~entire rectum~|~external cause codes: unspecified~|~hypertension, ctcae~|~hypertensive disease~|~interested~|~not otherwise specified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~bleeding from anus
poisoning~|~andorra~|~somnolence~|~not otherwise specified~|~signs and symptoms~|~and~|~and - dosing instruction fragment~|~biological factors~|~changed status~|~changing~|~drowsiness~|~drowsiness visual analogue scale~|~drugs - dental services~|~external cause codes: unspecified~|~indeterminate~|~mental status change~|~mental state~|~pharmaceutical preparations~|~relationshipconjunction - and~|~undetermined~|~undetermined finding~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~blood products laboratory testing~|~general symptom~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
poisoning~|~andorra~|~and~|~and - dosing instruction fragment~|~biological factors~|~drugs - dental services~|~indeterminate~|~pharmaceutical preparations~|~relationshipconjunction - and~|~specific qualifier value~|~this (eukaryote)~|~undetermined~|~undetermined finding~|~1/3 meter (distance vision finding)~|~near
dizziness~|~lightheadedness~|~hypogonadism~|~shock~|~mental status change~|~not otherwise specified
pain~|~facial injuries~|~craniocerebral trauma~|~not otherwise specified~|~specific qualifier value~|~andorra~|~pelvis~|~trauma to the abdomen~|~and~|~and - dosing instruction fragment~|~changed status~|~changing~|~mental state~|~relationshipconjunction - and~|~abdominal tenderness~|~administration method - pain~|~adverse event associated with pain~|~blood products laboratory testing~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~laboratory procedures~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)~|~usual severity pain
chest pain~|~cough frequency~|~cough, ctcae~|~coughing~|~have been coughing~|~how much distress cough~|~specific qualifier value~|~usual severity cough~|~chest pain:finding:point in time:^patient:ordinal
afternoon~|~not otherwise specified~|~good~|~language ability proficiency - good~|~language proficiency - good~|~specimen quality - good
dizziness~|~lightheadedness~|~headache~|~fatigue~|~headache, ctcae~|~not otherwise specified~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue
headache~|~headache, ctcae
changed status~|~changing~|~have~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~dyspnea~|~bcr protein, human~|~eye drops~|~disease~|~acute asthma~|~acute bronchospasm~|~all~|~bcr gene~|~bcr wt allele~|~eye drops brand of tetrahydrozoline~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~tissue membrane~|~universal restriction modifier (core metadata concept)~|~usual severity shortness of breath~|~all - localmarkupignore~|~all - tablerules
asthma~|~hyperventilation~|~asthma pathway~|~acute - triage code~|~admission level of care code - acute~|~exacerbation~|~fighting~|~in addition to~|~with - dosing instruction fragment~|~acute~|~acute inpatient encounter~|~symptoms and signs involving emotional state
muscle spasticity~|~fingers~|~back pain~|~hand~|~andorra~|~chest~|~wrist injuries~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~and~|~and - dosing instruction fragment~|~borg category-ratio 10 perceived exertion score 2~|~entire thorax~|~fighting~|~fingers, unit of measurement~|~intensity and distress 1~|~lower back (surface region)~|~lower back structure~|~mild (qualifier value)~|~not otherwise specified~|~relationshipconjunction - and~|~slight (qualifier value)~|~spasticity, ctcae~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~entity determiner - specific~|~specific qualifier value~|~traumatic secondary and recurrent hemorrhage and seroma
dehydration~|~anxiety~|~not otherwise specified~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~dehydration procedure~|~dehydration, ctcae~|~mental status change
aspirin~|~artificial cardiac pacemaker~|~hypertension, ctcae~|~hypertensive disease~|~not otherwise specified~|~external cause codes: unspecified~|~pacemaker ecg assessment~|~pacemaker procedure~|~pacemakers~|~specific qualifier value~|~specimen source codes - pacemaker~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness